Diagnostic Performance of Serum Calprotectin in Acute Appendicitis
SCP-AA
1 other identifier
observational
74
1 country
1
Brief Summary
This prospective observational study evaluated the diagnostic performance of serum calprotectin in patients presenting with acute abdominal pain and suspected acute appendicitis. Patients with histopathologically confirmed acute appendicitis were compared with patients diagnosed with nonspecific abdominal pain. Serum calprotectin levels were analyzed and compared with conventional inflammatory markers and the Alvarado score to assess their diagnostic value in acute appendicitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2015
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 19, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
April 21, 2016
CompletedFirst Submitted
Initial submission to the registry
June 2, 2026
CompletedFirst Posted
Study publicly available on registry
June 11, 2026
CompletedJune 11, 2026
June 1, 2026
4 months
June 2, 2026
June 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diagnostic accuracy of serum calprotectin for acute appendicitis
Comparison of serum calprotectin levels between patients with acute appendicitis and nonspecific abdominal pain.
At admission to the emergency department
Study Arms (2)
Acute Appendicitis
Patients with histopathologically confirmed acute appendicitis who underwent appendectomy.
Non-specific Abdominal Pain
Patients presenting with nonspecific abdominal pain without evidence of appendicitis during follow-up.
Interventions
Measurement of serum calprotectin levels using ELISA for diagnostic evaluation of acute appendicitis.
Eligibility Criteria
Adult patients presenting to the emergency department with acute abdominal pain and suspected acute appendicitis. Participants were divided into two groups: patients diagnosed with acute appendicitis and patients with non-specific abdominal pain.
You may qualify if:
- Age between 18 and 75 years
- Presentation to the emergency department with acute abdominal pain and suspected acute appendicitis
- Willingness to participate and provide informed consent
You may not qualify if:
- Previous abdominal surgery
- Chronic inflammatory or autoimmune disease
- Active infection other than suspected appendicitis
- Use of systemic anti-inflammatory or immunosuppressive therapy
- Pregnancy
- Incomplete clinical or laboratory data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fatih Sultan Mehmet Training and Research Hospital
Istanbul, ATASEHIR, 34752, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
fatih kilic, MD
Fatih Sultan Mehmet Training and Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2026
First Posted
June 11, 2026
Study Start
December 13, 2015
Primary Completion
April 19, 2016
Study Completion
April 21, 2016
Last Updated
June 11, 2026
Record last verified: 2026-06